Dr. Antonio Calles 🫁🚭 (@tony_calles) 's Twitter Profile
Dr. Antonio Calles 🫁🚭

@tony_calles

Medical Oncology 🏥 Hospital General Universitario Gregorio Marañón & @RuberInter ⎪@myESMO Faculty 🫁 ⎪#endlungcancer #lcsm

ID: 2155543177

linkhttp://www.linkedin.com/in/antonio-calles-001 calendar_today25-10-2013 19:57:31

23,23K Tweet

11,11K Takipçi

4,4K Takip Edilen

Dr. Antonio Calles 🫁🚭 (@tony_calles) 's Twitter Profile Photo
Dr. Antonio Calles 🫁🚭
@tony_calles

6 days ago

Amivantamab is not an easy drug as highlighted by Dr. Wolf, so the benefit has to outweigh the toxicity. #ESMO24 #LCSM How to incorporate patient-centered decisions in daily practice with the increasingly growing number of choices 4 patients with EGFRmutant NSCLC? EGFR Resisters

Amivantamab is not an easy drug as highlighted by Dr. Wolf, so the benefit has to outweigh the toxicity. #ESMO24 #LCSM How to incorporate patient-centered decisions in daily practice with the increasingly growing number of choices 4 patients with EGFRmutant NSCLC? <a href="/EGFRResisters/">EGFR Resisters</a>